NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Thursday that its fourth quarter revenues sank 24 percent as increases in laboratory services and collaboration revenues were offset by a decrease in product sales.

For the three months ended Dec. 31, the company reported total revenues of $1.0 million, down from $1.3 million in Q4 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.